The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non‐small cell lung cancer

BACKGROUND: Systemic inflammation, the most representative tumour–host interaction, plays a crucial role in disease progression and prognosis in patients with non‐small cell lung cancer (NSCLC). Few studies have compared the performance of existing haematological systemic inflammation biomarkers in...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Hailun, Ruan, Guotian, Wei, Lishuang, Deng, Li, Zhang, Qi, Ge, Yizhong, Song, Mengmeng, Zhang, Xi, Lin, Shiqi, Liu, Xiaoyue, Yang, Ming, Song, Chunhua, Zhang, Xiaowei, Shi, Hanping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067487/
https://www.ncbi.nlm.nih.gov/pubmed/36852672
http://dx.doi.org/10.1002/jcsm.13199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067487/
https://www.ncbi.nlm.nih.gov/pubmed/36852672
http://dx.doi.org/10.1002/jcsm.13199

Ejemplares similares